000904430 001__ 904430
000904430 005__ 20220131120426.0
000904430 0247_ $$2doi$$a10.1016/j.neubiorev.2021.02.015
000904430 0247_ $$2ISSN$$a0149-7634
000904430 0247_ $$2ISSN$$a1873-7528
000904430 0247_ $$2Handle$$a2128/30236
000904430 0247_ $$2altmetric$$aaltmetric:100194558
000904430 0247_ $$2pmid$$apmid:33587957
000904430 0247_ $$2WOS$$aWOS:000646741600004
000904430 037__ $$aFZJ-2021-06000
000904430 082__ $$a610
000904430 1001_ $$00000-0001-7824-1929$$aTrambaiolli, Lucas R.$$b0$$eCorresponding author
000904430 245__ $$aNeurofeedback training in major depressive disorder: A systematic review of clinical efficacy, study quality and reporting practices
000904430 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2021
000904430 3367_ $$2DRIVER$$aarticle
000904430 3367_ $$2DataCite$$aOutput Types/Journal article
000904430 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1642097236_4884
000904430 3367_ $$2BibTeX$$aARTICLE
000904430 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000904430 3367_ $$00$$2EndNote$$aJournal Article
000904430 520__ $$aMajor depressive disorder (MDD) is the leading cause of disability worldwide. Neurofeedback training has been suggested as a potential additional treatment option for MDD patients not reaching remission from standard care (i.e., psychopharmacology and psychotherapy). Here we systematically reviewed neurofeedback studies employing electroencephalography, or functional magnetic resonance-based protocols in depressive patients. Of 585 initially screened studies, 24 were included in our final sample (N = 480 patients in experimental and N = 194 in the control groups completing the primary endpoint). We evaluated the clinical efficacy across studies and attempted to group studies according to the control condition categories currently used in the field that affect clinical outcomes in group comparisons. In most studies, MDD patients showed symptom improvement superior to the control group(s). However, most articles did not comply with the most stringent study quality and reporting practices. We conclude with recommendations on best practices for experimental designs and reporting standards for neurofeedback training.
000904430 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000904430 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000904430 7001_ $$0P:(DE-Juel1)173070$$aKohl, Simon H.$$b1$$ufzj
000904430 7001_ $$0P:(DE-HGF)0$$aLinden, David E. J.$$b2
000904430 7001_ $$00000-0001-6587-2617$$aMehler, David M. A.$$b3
000904430 773__ $$0PERI:(DE-600)1498433-7$$a10.1016/j.neubiorev.2021.02.015$$gVol. 125, p. 33 - 56$$p33 - 56$$tNeuroscience & biobehavioral reviews$$v125$$x0149-7634$$y2021
000904430 8564_ $$uhttps://juser.fz-juelich.de/record/904430/files/Neurofeedback_depression_manuscript.pdf$$yOpenAccess
000904430 909CO $$ooai:juser.fz-juelich.de:904430$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000904430 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)173070$$aForschungszentrum Jülich$$b1$$kFZJ
000904430 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000904430 9141_ $$y2021
000904430 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-31
000904430 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-31
000904430 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-31
000904430 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-01-31
000904430 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEUROSCI BIOBEHAV R : 2019$$d2021-01-31
000904430 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-01-31
000904430 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-31
000904430 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-31
000904430 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000904430 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-01-31
000904430 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNEUROSCI BIOBEHAV R : 2019$$d2021-01-31
000904430 915__ $$0StatID:(DE-HGF)1120$$2StatID$$aDBCoverage$$bBIOSIS Reviews Reports And Meetings$$d2021-01-31
000904430 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-31
000904430 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2021-01-31$$wger
000904430 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-31
000904430 9201_ $$0I:(DE-Juel1)INM-11-20170113$$kINM-11$$lJara-Institut Quantum Information$$x0
000904430 9801_ $$aFullTexts
000904430 980__ $$ajournal
000904430 980__ $$aVDB
000904430 980__ $$aUNRESTRICTED
000904430 980__ $$aI:(DE-Juel1)INM-11-20170113